Takeaways from this week in optometry: August 3-August 7

AMA resolution backs classifying myopia as a disease, aiming to expand insurance coverage for pediatric myopia control treatments.

SightGlass Vision reports the milestone just 1 year after reaching 1 million users.

The findings extend prior Asian efficacy data to a diverse North American cohort for Stellest lenses.

Noha Ekdawi, MD, FAAP, explains why pediatric myopia demands individualized, progression-based management.

Monica Jong, BOptom, PhD, FAAO, FBCLA, discussed the latest findings on Stellest lenses' effectiveness in myopia progression control and her advice for optometrists integrating the lenses into practice.

Roman-Lantzy, PhD, gives an urgent plea to eye care providers, whom she calls "the gatekeepers of the entire story" for pediatric patients with CVI.

Mary Beth Yackey, OD, outlines all that you need to know about the role of oculomics in eye care.

A recent study found that migraines were associated with higher adverse vision outcomes in a cohort of Norwegian adolescents.